ViiV Healthcare Presents Phase III Data at AIDS 2018 from Landmark GEMINI Studies Showing Two-Drug Regimen of Dolutegravir and Lamivudine Has Similar Efficacy to a Three-Drug Regimen in Treatment Naï

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/9/2026

1. TTAN
2. BRZE
3. CHYM
4. USO
5. IRT
6. QCOM
7. ASO
8. SPY
9. EVMN
10. AAPL

Go back to ViiV Healthcare Presents Phase III Data at AIDS 2018 from Landmark GEMINI Studies Showing Two-Drug Regimen of Dolutegravir and Lamivudine Has Similar Efficacy to a Three-Drug Regimen in Treatment Naï
GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 48.64 +0.10 (0.21%)
Previous Close $48.54    52 Week High $45.58 
Open $48.81    52 Week Low $37.82 
Day High $49.16    P/E N/A 
Day Low $48.60    EPS $0.00 
Volume 588,543       

GLAXOSMITHKLINE PLC (NYSE: GSK) Delayed: 48.64 +0.10 (0.21%)
Previous Close $48.54    52 Week High $45.58 
Open $48.81    52 Week Low $37.82 
Day High $49.16    P/E N/A 
Day Low $48.60    EPS $0.00 
Volume 588,543       

Pfizer Inc. (NYSE: PFE) Delayed: 27.83 +0.04 (0.14%)
Previous Close $27.79    52 Week High $37.39 
Open $27.76    52 Week Low $28.25 
Day High $27.89    P/E 16.87 
Day Low $27.57    EPS $1.65 
Volume 5,338,921